(Reuters) – Merck & Co will buy drugmaker Acceleron Pharma Inc for about $11.5 billion, the companies said on Thursday, as the U.S. pharmaceutical giant looks to beef up its portfolio with drugs for rare diseases.
(Reporting by Mrinalika Roy in Bengaluru; Editing by Vinay Dwivedi and Sriraj kalluvila)
